Vesalius Biocapital III
Investor profile
Vesalius Biocapital III has backed 4 European tech companies across 4 funding rounds between 2018 and 2024, joining rounds totalling €83M. Most active in Healthtech. Data as of Nov 2026.
Deals
4
distinct rounds
Companies
4
backed
Active span
2018–2024
7 yrs
Total round €
€83M
sum of rounds joined
Deals by year
distinct rounds / yearVesalius Biocapital III — deals by year — interactive chart.
Data table
| Vesalius Biocapital III — deals by year | |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Top sectors
by dealsVesalius Biocapital III — top sectors — interactive chart.
Data table
| Vesalius Biocapital III — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsVesalius Biocapital III — stages — interactive chart.
Data table
| Vesalius Biocapital III — stages | |
|---|---|
| Series A | 1 |
| Series B | 1 |
| Series C | 1 |
| Other | 1 |
Countries
by dealsVesalius Biocapital III — countries — interactive chart.
Data table
| Vesalius Biocapital III — countries | |
|---|---|
| Germany | 2 |
| Portugal | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Armilar Venture Partners1
- Bayern Kapital1
- BioGeneration Ventures1
- BioMedPartners1
- BlueCrow Capital1
- Boehringer Ingelheim Venture Fund1
- Brandon Capital1
- Coparion1
- EMBL Ventures1
- Epidarex Capital1
- Evotec1
- Forbion1
- FSNB Health & Care1
- GIMV1
- Green Innovations1
- Iberis Capital1
- Jeito Capital1
- Novartis Venture Fund1
- Shilling VC1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| CatalYm | Germany | 1 | €50M |
| Topas Therapeutics | Germany | 1 | €18M |
| tonic app | Portugal | 1 | €11M |
| Sword Health | Portugal | 1 | €3.7M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| CatalYm | Series C | €50M | 2022-11 |
| Topas Therapeutics | Series B | €18M | 2021-07 |
| tonic app | Series A | €11M | 2024-03 |
| Sword Health | Other | €3.7M | 2018-02 |